Skip to content
HowShorted

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. short interest in 2018

In 2018, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s disclosed short interest ran from 9.86% of shares outstanding on 12 Jan 2018 to 8.39% on 31 Dec 2018, a change of -1.47 percentage points. The year's high was 11.31% on 15 Feb 2018 and its low 6.17% on 14 Sep 2018, averaging 8.17% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.90 days on 30 Apr 2018. Full history: PACIFIC BIOSCIENCES OF CALIFORNIA, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. in 2018

2018 in figures

Start of year
9.86% (12 Jan 2018)
End of year
8.39% (31 Dec 2018)
Change
-1.47 pp
High
11.31% (15 Feb 2018)
Low
6.17% (14 Sep 2018)
Average
8.17%
Highest days to cover
27.90 (30 Apr 2018)
SEC filings marked
8

Every report in 2018

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20189.86%8.22
31 Jan 20189.47%7.82
15 Feb 201811.31%10.94results (8-K)
28 Feb 201810.09%17.6810-K filed
15 Mar 201811.17%13.25
29 Mar 20189.01%9.36
13 Apr 20189.68%15.33
30 Apr 20188.57%27.90
15 May 20188.45%12.8210-Q filed, results (8-K)
31 May 20187.86%14.01
15 Jun 20187.56%10.71
29 Jun 20188.09%7.99
13 Jul 20187.89%16.66
31 Jul 20187.26%12.64
15 Aug 20187.09%7.77results (8-K), 10-Q filed
31 Aug 20187.13%12.09
14 Sep 20186.17%4.25
28 Sep 20186.80%6.51
15 Oct 20186.80%5.91
31 Oct 20186.44%12.27
15 Nov 20186.58%1.00results (8-K), 10-Q filed
30 Nov 20186.83%3.96
14 Dec 20187.67%3.96
31 Dec 20188.39%6.47

See also: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.